Moderna Inc (NASDAQ:MRNA)
| 79.82 Delayed Data As of Dec 01 |  +2.12 / +2.73%Today’s Change | 62.55 Today|||52-Week Range 217.25 | -55.56% Year-to-Date |
Latest MRNA News | Press Releases
| Novavax's (NVAX) Updated COVID Jab Gets WHO Nod for Emergency Use Nov 29 / Zacks.com - Paid Partner Content | 3 Biotech Stocks That Could Be Millionaire Makers Nov 22 / MotleyFool.com - Paid Partner Content |
| Arcturus' (ARCT) CF Drug Gets FDA's Orphan Status, Stock Up Nov 28 / Zacks.com - Paid Partner Content | Vertex (VRTX) Non-Cystic Fibrosis Pipeline Boosts Stock This Year Nov 21 / Zacks.com - Paid Partner Content |
| Moderna (MRNA): A Fair Valuation in Today's Market? Nov 28 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 77.70 |
| Today’s open | 76.50 |
| Day’s range | 74.52 - 80.26 |
| Volume | 235,583 |
| Average volume (3 months) | 4,125,957 |
| Market cap | $30.4B |
Data as of 4:00pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | -29.90% |
| Earnings growth (this year) | -112.01% |
| Earnings growth (next 5 years) | -51.00% |
| Revenue growth (last year) | +3.78% |
| P/E ratio | NM |
| Price/Sales | 3.91 |
| Price/Book | 1.61 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BIIBBiogen | +0.53 | +0.23% |
| ---- | ||
| BMRNBiomarin Pharmaceuti... | +1.37 | +1.50% |
| ILMNIllumina Inc | +7.85 | +7.70% |
Data as of 4:00pm ET, 12/01/2023
Financials
| Next reporting date | February 22, 2024 |
| EPS forecast (this quarter) | $0.97 |
| Annual revenue (last year) | $19.1B |
| Annual profit (last year) | $8.4B |
| Net profit margin | 43.76% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
